BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31981078)

  • 21. SEOM clinical guideline thyroid cancer (2019).
    Gallardo E; Medina J; Sánchez JC; Viúdez A; Grande E; Porras I; Ramón Y Cajal T; Trigo J; Iglesias L; Capdevila J
    Clin Transl Oncol; 2020 Feb; 22(2):223-235. PubMed ID: 32006340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of ultrasound in primary workup of cervical cancer staging (ESGO, ESTRO, ESP cervical cancer guidelines).
    Fischerová D; Cibula D
    Ceska Gynekol; 2019; 84(1):40-48. PubMed ID: 31213057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term survival following neoadjuvant chemotherapy and concomitant radiochemotherapy in locally advanced cervical cancer: results of the Oncology Institute "Prof. Dr. Ion Chiricuta" experience.
    Marita A; Ordeanu C; Rancea A; Nicolae T; Nagy VM
    J Med Life; 2018; 11(1):42-50. PubMed ID: 29696064
    [No Abstract]   [Full Text] [Related]  

  • 24. Cervical cancer.
    Moore DH
    Obstet Gynecol; 2006 May; 107(5):1152-61. PubMed ID: 16648423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current Therapeutic Approaches in Cervical Cancer Based on the Stage of the Disease: Is There Room for Improvement?
    Dicu-Andreescu IG; Marincaș AM; Ungureanu VG; Ionescu SO; Prunoiu VM; Brătucu E; Simion L
    Medicina (Kaunas); 2023 Jun; 59(7):. PubMed ID: 37512041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotherapy With Radiotherapy and Chemoradiotherapy for Cervical Cancer.
    Feng CH; Mell LK; Sharabi AB; McHale M; Mayadev JS
    Semin Radiat Oncol; 2020 Oct; 30(4):273-280. PubMed ID: 32828383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perioperative morbidity and rate of upstaging after laparoscopic staging for patients with locally advanced cervical cancer: results of a prospective randomized trial.
    Köhler C; Mustea A; Marnitz S; Schneider A; Chiantera V; Ulrich U; Scharf JP; Martus P; Vieira MA; Tsunoda A
    Am J Obstet Gynecol; 2015 Oct; 213(4):503.e1-7. PubMed ID: 25986030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer.
    Cibula D; Pötter R; Planchamp F; Avall-Lundqvist E; Fischerova D; Haie Meder C; Köhler C; Landoni F; Lax S; Lindegaard JC; Mahantshetty U; Mathevet P; McCluggage WG; McCormack M; Naik R; Nout R; Pignata S; Ponce J; Querleu D; Raspagliesi F; Rodolakis A; Tamussino K; Wimberger P; Raspollini MR
    Int J Gynecol Cancer; 2018 May; 28(4):641-655. PubMed ID: 29688967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized phase III trial of platinum chemotherapy plus paclitaxel with bevacizumab and atezolizumab versus platinum chemotherapy plus paclitaxel and bevacizumab in metastatic (stage IVB), persistent, or recurrent carcinoma of the cervix: the BEATcc study (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030).
    Grau JF; Farinas-Madrid L; Oaknin A
    Int J Gynecol Cancer; 2020 Jan; 30(1):139-143. PubMed ID: 31645423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Immunotherapy in the Management of Locally Advanced and Recurrent/Metastatic Cervical Cancer.
    Dyer BA; Zamarin D; Eskandar RN; Mayadev JM
    J Natl Compr Canc Netw; 2019 Jan; 17(1):91-97. PubMed ID: 30659133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Burden of lymphatic disease predicts efficacy of adjuvant radiation and chemotherapy in FIGO 2018 stage IIICp cervical cancer.
    Bogani G; Vinti D; Murgia F; Chiappa V; Leone Roberti Maggiore U; Martinelli F; Ditto A; Raspagliesi F
    Int J Gynecol Cancer; 2019 Nov; 29(9):1355-1360. PubMed ID: 31422352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Preventive vaccines and immunotherapy clinical trials against cervical cancer].
    Valdespino-Gómez VM
    Cir Cir; 2005; 73(1):57-69. PubMed ID: 15888272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer.
    Cibula D; Pötter R; Planchamp F; Avall-Lundqvist E; Fischerova D; Haie-Meder C; Köhler C; Landoni F; Lax S; Lindegaard JC; Mahantshetty U; Mathevet P; McCluggage WG; McCormack M; Naik R; Nout R; Pignata S; Ponce J; Querleu D; Raspagliesi F; Rodolakis A; Tamussino K; Wimberger P; Raspollini MR
    Virchows Arch; 2018 Jun; 472(6):919-936. PubMed ID: 29725757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Definitive chemoradiotherapy for advanced cervical cancer: should it be different in the elderly?
    Caires IQ; Souza KT; Negrão MV; de Oliveira JA; Barroso-Sousa R; de Lima RC; Hoff PM; Diz Mdel P
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():86-9. PubMed ID: 26182837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The development of priority cervical cancer trials: a Gynecologic Cancer InterGroup report.
    Kitchener HC; Hoskins W; Small W; Thomas GM; Trimble EL;
    Int J Gynecol Cancer; 2010 Aug; 20(6):1092-100. PubMed ID: 20683424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal uptake rates for initial treatments for cervical cancer in concordance with guidelines in Australia and Canada: Results from two large cancer facilities.
    Kang YJ; O'Connell DL; Tan J; Lew JB; Demers A; Lotocki R; Kliewer EV; Hacker NF; Jackson M; Delaney GP; Barton M; Canfell K
    Cancer Epidemiol; 2015 Aug; 39(4):600-11. PubMed ID: 26004990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
    Landoni F; Sartori E; Maggino T; Zola P; Zanagnolo V; Cosio S; Ferrari F; Piovano E; Gadducci A
    Gynecol Oncol; 2014 Mar; 132(3):611-7. PubMed ID: 24342439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Neoadjuvant Chemotherapy Plus Radical Surgery as Front Line Treatment Strategy in Patients Affected by FIGO Stage III Cervical Cancer.
    Di Donato V; Schiavi MC; Ruscito I; Visentin VS; Palaia I; Marchetti C; Fischetti M; Monti M; Muzii L; Benedetti Panici P
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):841-849. PubMed ID: 27678502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SEOM guidelines for the management of Malignant Melanoma 2015.
    Berrocal A; Arance A; Espinosa E; Castaño AG; Cao MG; Larriba JL; Martín JA; Márquez I; Soria A; Algarra SM
    Clin Transl Oncol; 2015 Dec; 17(12):1030-5. PubMed ID: 26669314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of treatment failure following radiotherapy with combination chemotherapy for patients with high-risk stage IIB cervical carcinoma.
    Park TK; Kwon JY; Kim SW; Kim SH; Kim SN; Kim GE
    Int J Clin Oncol; 2004 Apr; 9(2):120-4. PubMed ID: 15108044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.